| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 14.72% | Barclays | $34 → $48 | Maintains | Overweight |
| 05/11/2023 | -11.57% | B of A Securities | $34 → $37 | Maintains | Buy |
| 05/11/2023 | 29.78% | Citigroup | $51.5 → $54.3 | Maintains | Buy |
| 05/11/2023 | -18.74% | Barclays | $31 → $34 | Maintains | Overweight |
| 03/03/2023 | -13.96% | HSBC | $35 → $36 | Maintains | Buy |
| 02/28/2023 | -25.91% | Barclays | $25 → $31 | Maintains | Overweight |
| 02/09/2023 | 23.09% | Citigroup | $48 → $51.5 | Maintains | Buy |
| 11/28/2022 | -50.62% | Jefferies | → $20.66 | Initiates Coverage On | → Buy |
| 10/28/2022 | -40.25% | Barclays | $40 → $25 | Maintains | Overweight |
| 06/21/2022 | 40.06% | Citigroup | $26.8 → $58.6 | Maintains | Buy |
| 05/11/2022 | -35.95% | Citigroup | $51.5 → $26.8 | Maintains | Buy |
| 04/05/2022 | 24.28% | UBS | $47 → $52 | Maintains | Buy |
| 03/24/2022 | -11.09% | China Renaissance | → $37.2 | Initiates Coverage On | → Buy |
| 03/23/2022 | -2.01% | Morgan Stanley | $49 → $41 | Maintains | Overweight |
| 02/28/2022 | -4.4% | Barclays | $38 → $40 | Maintains | Overweight |
| 02/08/2022 | -23.52% | Barclays | → $32 | Initiates Coverage On | → Overweight |
| 01/12/2022 | — | Macquarie | Initiates Coverage On | → Outperform | |
| 12/07/2021 | 2.77% | Needham | $37 → $43 | Maintains | Buy |
| 10/28/2021 | 2.77% | Bernstein | → $43 | Initiates Coverage On | → Outperform |
| 10/14/2021 | 3.73% | Nomura Instinet | → $43.4 | Initiates Coverage On | → Buy |
| 03/11/2021 | -11.57% | Needham | → $37 | Initiates Coverage On | → Buy |
| 02/01/2021 | -16.35% | Deutsche Bank | → $35 | Initiates Coverage On | → Hold |
| 01/19/2021 | 6.36% | Jefferies | → $44.5 | Initiates Coverage On | → Buy |
| 01/06/2021 | 0.38% | B of A Securities | → $42 | Initiates Coverage On | → Buy |
| 11/16/2020 | 8.99% | Citigroup | → $45.6 | Upgrades | Neutral → Buy |
| 11/04/2020 | -35.47% | Citigroup | → $27 | Initiates Coverage On | → Neutral |
| 08/06/2020 | -49.81% | Bernstein | → $21 | Initiates Coverage On | → Outperform |
What is the target price for Li Auto (LI)?
The latest price target for Li Auto (NASDAQ: LI) was reported by Barclays on August 10, 2023. The analyst firm set a price target for $48.00 expecting LI to rise to within 12 months (a possible 14.72% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Li Auto (LI)?
The latest analyst rating for Li Auto (NASDAQ: LI) was provided by Barclays, and Li Auto maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Li Auto (LI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Li Auto, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Li Auto was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
Is the Analyst Rating Li Auto (LI) correct?
While ratings are subjective and will change, the latest Li Auto (LI) rating was a maintained with a price target of $34.00 to $48.00. The current price Li Auto (LI) is trading at is $41.84, which is within the analyst's predicted range.